EssilorLuxottica to acquire Optegra clinics

EssilorLuxottica (ESLOY) and MidEuropa announced that they entered into an agreement for EssilorLuxottica to acquire Optegra, an ophthalmology platform operating in five key European markets: the UK, Czech Republic, Poland, Slovakia and the Netherlands. The Optegra group, under the Optegra, Lexum and Iris brands, operates an extensive network of over 70 eye hospitals and diagnostic facilities across Europe, offering medically necessary ophthalmic treatments and elective vision correction procedures supported by AI in pre- and post-op stages. “With the acquisition of Optegra, we are stepping into a new frontier – one where comprehensive eyecare, advanced diagnostics, therapeutic interventions and surgical treatments come together in one seamless platform,” commented Francesco Milleri, Chairman and CEO, and Paul du Saillant, Deputy CEO at EssilorLuxottica. The transaction is expected to close later in 2025 pending regulatory approvals and other customary closing conditions.